These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 19071066

  • 21. Results of Roux-en-Y gastric bypass in morbidly obese vs superobese patients: similar body weight loss, correction of comorbidities, and improvement of quality of life.
    Suter M, Calmes JM, Paroz A, Romy S, Giusti V.
    Arch Surg; 2009 Apr; 144(4):312-8; discussion 318. PubMed ID: 19380643
    [Abstract] [Full Text] [Related]

  • 22. Effect of histaminergic manipulation on weight in obese adults: a randomized placebo controlled trial.
    Barak N, Greenway FL, Fujioka K, Aronne LJ, Kushner RF.
    Int J Obes (Lond); 2008 Oct; 32(10):1559-65. PubMed ID: 18698316
    [Abstract] [Full Text] [Related]

  • 23. Effects of gastric bubble implant on weight change with and without compliance with a behavior modification program.
    Barkin JS, Reiner DK, Goldberg RI, Phillips RS.
    Am J Gastroenterol; 1988 Sep; 83(9):930-4. PubMed ID: 3414646
    [Abstract] [Full Text] [Related]

  • 24. [Operative technique and outcome in metabolic surgery: conventional and banded gastric bypass].
    Busch P, Wolter S, Rawnaq T, Kaifi JT, Aberle J, Izbicki JR, Mann O.
    Zentralbl Chir; 2009 Feb; 134(1):32-7. PubMed ID: 19242880
    [Abstract] [Full Text] [Related]

  • 25. Intragastric balloon for weight loss: results in 100 individuals followed for at least 2.5 years.
    Dastis NS, François E, Deviere J, Hittelet A, Ilah Mehdi A, Barea M, Dumonceau JM.
    Endoscopy; 2009 Jul; 41(7):575-80. PubMed ID: 19588283
    [Abstract] [Full Text] [Related]

  • 26. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial.
    de Oliveira JC, Martinelli M, Nishioka SA, Varejão T, Uipe D, Pedrosa AA, Costa R, D'Avila A, Danik SB.
    Circ Arrhythm Electrophysiol; 2009 Feb; 2(1):29-34. PubMed ID: 19808441
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Intra-abdominal vagal blocking (VBLOC therapy): clinical results with a new implantable medical device.
    Camilleri M, Toouli J, Herrera MF, Kulseng B, Kow L, Pantoja JP, Marvik R, Johnsen G, Billington CJ, Moody FG, Knudson MB, Tweden KS, Vollmer M, Wilson RR, Anvari M.
    Surgery; 2008 Jun; 143(6):723-31. PubMed ID: 18549888
    [Abstract] [Full Text] [Related]

  • 29. Laparoscopic adjustable gastric banding for morbidly obese adolescents affects android fat loss, resolution of comorbidities, and improved metabolic status.
    Nadler EP, Reddy S, Isenalumhe A, Youn HA, Peck V, Ren CJ, Fielding GA.
    J Am Coll Surg; 2009 Nov; 209(5):638-44. PubMed ID: 19854406
    [Abstract] [Full Text] [Related]

  • 30. Long-term weight loss decreases the nontraditional cardiovascular risk factors interleukin-18 and matrix metalloproteinase-9 in obese subjects.
    Madsen EL, Bruun JM, Skogstrand K, Hougaard DM, Christiansen T, Richelsen B.
    Metabolism; 2009 Jul; 58(7):946-53. PubMed ID: 19409578
    [Abstract] [Full Text] [Related]

  • 31. Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trial.
    Stoch SA, Saag KG, Greenwald M, Sebba AI, Cohen S, Verbruggen N, Giezek H, West J, Schnitzer TJ.
    J Rheumatol; 2009 Aug; 36(8):1705-14. PubMed ID: 19487264
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Failure of adjustable gastric banding: starting BMI of 46 kg/m2 is a fulcrum of success and failure.
    Snyder B, Scarborough T, Yu S, Wilson E.
    Surg Obes Relat Dis; 2009 Aug; 5(3):310-6. PubMed ID: 19136307
    [Abstract] [Full Text] [Related]

  • 34. High protein diets decrease total and abdominal fat and improve CVD risk profile in overweight and obese men and women with elevated triacylglycerol.
    Clifton PM, Bastiaans K, Keogh JB.
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):548-54. PubMed ID: 19179060
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Implantable gastric stimulation for the treatment of severe obesity: the American experience.
    Shikora SA, Storch K, Investigational team, 2004 ABS Consensus Conference.
    Surg Obes Relat Dis; 2005 Oct; 1(3):334-42. PubMed ID: 16925244
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effect of weight loss after Roux-en-Y gastric bypass, on renal function and blood pressure in morbidly obese patients.
    Serpa Neto A, Bianco Rossi FM, Dal Moro Amarante R, Alves Buriti N, Cunha Barbosa Saheb G, Rossi M.
    J Nephrol; 2009 Oct; 22(5):637-46. PubMed ID: 19809997
    [Abstract] [Full Text] [Related]

  • 40. A double-blind randomized controlled trial of electromagnetic stimulation of the pelvic floor vs sham therapy in the treatment of women with stress urinary incontinence.
    Gilling PJ, Wilson LC, Westenberg AM, McAllister WJ, Kennett KM, Frampton CM, Bell DF, Wrigley PM, Fraundorfer MR.
    BJU Int; 2009 May; 103(10):1386-90. PubMed ID: 19154474
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.